CLINICAL_TRIALS ClinicalTrials.gov record update

Characterizing the Effect of Dopamine on Markers of Lymph Re-circulation in Fontan-associated Protein-losing Enteropathy

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03322345
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:44.846438+00:00
Published At: 2025-03-13T00:00:00+00:00
Record Updated At: 2025-03-13
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Dopamine", "Protein-Losing Enteropathies", "Lymphatic System", "Lymph", "Catecholamine", "Single-ventricle", "Congenital Heart Disease"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-03-13"
protocolSection.identificationModule.nctId: "NCT03322345"
protocolSection.identificationModule.officialTitle: "Characterizing the Effect of Dopamine on Markers of Lymph Re-circulation in Fontan-associated Protein-losing Enteropathy"
protocolSection.statusModule.overallStatus: "ENROLLING_BY_INVITATION"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.